Rentschler Biopharma announces largest single investment at its headquarters in Germany
October 24, 2024 01:30 ET
|
Rentschler Biopharma SE
Construction of a new buffer media facility in LaupheimLargest investment in the German site; project duration of approx. three yearsContinuous modernization, automation, and digitalization of the...
Rentschler Biopharma Announces New State-of-the-Art Production Line in Massachusetts is Fully Operational
July 11, 2024 08:00 ET
|
Rentschler Biopharma SE
Largest expansion in company’s 150+-year history opensMajor client project already underway; new clients actively being onboarded LAUPHEIM, Germany and MILFORD, Mass., July 11, 2024 (GLOBE...
Rentschler Biopharma Appoints Patrick Meyer as Global Head BD Sales and Alliance Management
May 28, 2024 07:00 ET
|
Rentschler Biopharma SE
LAUPHEIM, Germany and MILFORD, Mass. and STEVENAGE, United Kingdom, May 28, 2024 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization...
Rentschler Biopharma Appoints Patrick Cushing as VP Operations for U.S. Subsidiary
May 02, 2024 08:00 ET
|
Rentschler Biopharma SE
LAUPHEIM, Germany and MILFORD, Mass. and STEVENAGE, United Kingdom, May 02, 2024 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization...
Rentschler Biopharma Takes Home the Gold in 20th Annual Team Massachusetts Economic Impact Awards
March 13, 2024 09:30 ET
|
Rentschler Biopharma SE
Company honored with highest award for Central Massachusetts regionNew state-of-the-art Rentschler Biopharma Manufacturing Center (RBMC) facility slated to open for business later this year ...
Rentschler Biopharma contributes to nearly 25% of FDA approved biopharmaceuticals in 2023
March 06, 2024 04:00 ET
|
Rentschler Biopharma SE
Exceptional capabilities in guiding therapies from early-stage development through to market based on over 50 years of biotech experience LAUPHEIM, Germany and MILFORD, Mass. and STEVENAGE, United...
Senta Brandt and Gerrick Rodrigues appointed to Global Leadership Positions at Rentschler Biopharma
February 06, 2024 08:00 ET
|
Rentschler Biopharma SE
Senta Brandt promoted to global position of Head of TransformationGerrick Rodrigues promoted to Global Head of IT LAUPHEIM, Germany and MILFORD, Mass. and STEVENAGE, United Kingdom, Feb. 06, 2024 ...
Rentschler Biopharma Announces Major Client Project for New U.S. Facility at Milford, MA Site
December 20, 2023 07:00 ET
|
Rentschler Biopharma SE
State-of-the-art Rentschler Biopharma Manufacturing Center (RBMC) facility slated to open for business next year LAUPHEIM, Germany and MILFORD, Mass., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Rentschler...
Rentschler Biopharma SE appoints Gunnar Voss von Dahlen as Chief Financial Officer and completes Executive Board
December 07, 2023 04:00 ET
|
Rentschler Biopharma SE
LAUPHEIM, Germany and MILFORD, Mass. and STEVENAGE, United Kingdom, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading contract development and manufacturing organization (CDMO)...
Rentschler Biopharma appoints Benedikt von Braunmuehl as Chief Executive Officer
September 19, 2023 05:00 ET
|
Rentschler Biopharma SE
Benedikt von Braunmuehl, a transformational leader with a 30-year track record in the global healthcare industry, is named CEO Rentschler Biopharma SECompany also announces appointment of Tom Roberts,...